FDA approves updated COVID-19 vaccines targeting XFG variant

The FDA has authorized updated COVID-19 vaccines from Moderna, Novavax-Sanofi, and Pfizer-BioNTech to address the currently dominant XFG variant. While distribution to providers is authorized, uncertainty persists regarding insurance coverage and patient out-of-pocket costs.